PLEASANTON — 10x Genomics has marked a new phase in its remarkable expansion by opening a modern office building that has just sprouted in Pleasanton, coupled with plans for even more growth at ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. The company ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge ...

Sept 14 (Reuters) - Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics (TXG.O), opens new tab and Stanford University on ...

Two months after launching the Arc Virtual Cell Atlas comprising over 300 million cells, the initiative is now benefiting from new partnerships with 10x Genomics and Ultima Genomics, industry ...

10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x Genomics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end ...

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors should know. 10x Genomics beat analysts’ revenue expectations by 3. ...